Ratings
0
Nobody has rated this yet. Be the first!
Works
10
40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999
35th Annual Meeting of the European Association for the Study of Diabetes
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies
Introduction: new approaches to managing diabetic dyslipidaemia
Is rosiglitazone associated with increased risk for cardiovascular events?
Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.
Multimodal therapy of dyslipidemia
